New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
18:29 EDTGERN, MTZ, GALE, ICPT, DSTI, CALL, MM, SMG, HALO, TRAK, SFM, HEAR, NUAN, CEMP, GSATOn The Fly: After Hours Movers
UP AFTER EARNINGS: DealerTrack (TRAK), up 11.3%... DTS Inc. (DSTI), up 12.8%... Globalstar (GSAT), up 1.6%... Halozyme Therapeutics (HALO), up 2.4%. ALSO HIGHER: Intercept Pharmaceuticals (ICPT), up 57.7% after announcing that 46% of OCA group met FLINT endpoint as well as reporting second quarter results... Cempra (CEMP), up 5.8% following Intercept Pharmaceuticals' FLINT announcement... Scotts Miracle-Gro (SMG), up 3.6% after board approves a $500M share repurchase authorization and announces a $2.00 per share special dividend. DOWN AFTER EARNINGS: Galena Biopharma (GALE), down 13.4%... Nuance Communications (NUAN), down 9.7%... Millennial Media (MM), down 7.1%... MasTec (MTZ), down 3.6%... Turtle Beach (HEAR), down 3.5%... magicJack (CALL), down 5.8%... Geron (GERN), down 2.4%. ALSO LOWER: Sprouts Farmers Market (SFM), down 3.7% after filing to sell 15M shares of common stock for holders.
News For TRAK;DSTI;GSAT;HALO;ICPT;CEMP;SMG;GALE;NUAN;MM;MTZ;HEAR;CALL;GERN;SFM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 31, 2015
06:26 EDTGSATGlobalstar files automatic mixed securities shelf
05:18 EDTMTZMasTec sees Q2 adjusted EPS 10c-13c, consensus 28c
Sees Q2 revenue approximately $1.1B, consensus $1.02B. The company also announced that it expects to file its Quarterly Report on Form 10-Q for the quarterly period ended March 31 not later than August 10 and expects that final reported net loss attributable to MasTec will be reduced by approximately $0.5M as compared to the company's previously disclosed unaudited, preliminary net loss attributable to MasTec. The company's Q2 results have been negatively affected by significant disruptions caused by heavy rains and flooding in many of its work areas from the Gulf of Mexico coast to the Canadian border. This rain and flooding has negatively affected Q2 productivity and margins across various segments. In addition, Q2 operating results for the company's Electrical Transmission segment are significantly weaker than initially expected due to lower revenues, the impact of rain and flooding and project inefficiencies. This segment has been the primary focus of the Audit Committee independent investigation over the past several months, requiring a significant amount of time and effort by its management team. These matters have diverted the attention of management from the operations of its business and its performance in obtaining new project awards has suffered during this period. We currently expect this segment will underperform and will show continued weakness in revenue and operating profit during the second half of 2015 as it seeks to replenish its backlog and normalize its operations.
05:16 EDTMTZMasTec finds certain accounting adjustments appropriate in FY14 results
Subscribe for More Information
July 30, 2015
12:40 EDTCEMPCempra price target raised to $58 from $50 at SunTrust
Subscribe for More Information
10:44 EDTSFMWhole Foods earnings miss drags down organic foods space
Subscribe for More Information
July 29, 2015
16:25 EDTCEMPCempra reports Q2 EPS (57c), consensus (42c)
Subscribe for More Information
10:00 EDTSFMOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: 3D Systems (DDD) upgraded to Neutral from Underperform at Longbow... AK Steel (AKS) upgraded to Outperform from Neutral at Macquarie... Ally Financial (ALLY) upgraded to Outperform from Neutral at Credit Suisse... Amazon.com (AMZN) upgraded to Buy from Hold at Stifel... Arrow Electronics (ARW) upgraded to Buy from Underperform at CLSA... Beacon Roofing (BECN) upgraded to Buy from Neutral at CL King... Citrix (CTXS) upgraded to Outperform at Baird... Commvault (CVLT) upgraded to Buy from Hold at Jefferies... FireEye (FEYE) upgraded on positive checks, business mdoel changes at Oppenheimer... Hibbett Sports (HIBB) upgraded to Neutral from Underperform at Sterne Agee CRT... Integra LifeSciences (IART) upgraded to Outperform at Raymond James... M/A-COM (MTSI) upgraded to Buy from Hold at Needham... Norsk Hydro (NHYDY) upgraded to Neutral from Underperform at Exane BNP Paribas... NuVasive (NUVA) upgraded to Outperform from Market Perform at Northland... SM Energy (SM) upgraded to Outperform from Market Perform at Raymond James... Scorpio Bulkers (SALT) upgraded to Buy from Hold at Deutsche Bank... Sirius XM (SIRI) upgraded to Buy from Hold at Wunderlich... Sprouts Farmers Markets (SFM) upgraded to Neutral from Underperform at Longbow... Supervalu (SVU) upgraded to Equal Weight from Underweight at Morgan Stanley... Waters (WAT) upgraded to Outperform from Market Perform at Wells Fargo... Wells Fargo (WFC) upgraded to Buy from Neutral at Guggenheim... Williams-Sonoma (WSM) upgraded to Overweight from Neutral at JPMorgan... YRC Worldwide (YRCW) upgraded to Strong Buy at Raymond James.
08:06 EDTTRAKDealerTrack secures customer wins for incadea.myengine automotive DMS solution
Dealertrack Technologies announced it has secured several customer wins for its incadea.myengine automotive DMS solution. Munich-based incadea will strengthen its presence in several growth markets, including Europe, Africa and Latin America, by leveraging the uniquely competitive value of its Microsoft Dynamics NAV 2013-based scalable DMS solution.
07:15 EDTGALEGalena announces U.S. product launch of Zuplenz Oral Soluble Film
Subscribe for More Information
06:16 EDTSFMSprouts Farmers Markets upgraded to Neutral from Underperform at Longbow
Longbow upgraded Sprouts Farmers Markets to Neutral due to valuation.
July 28, 2015
11:34 EDTCEMPCempra management to meet with Roth Capital
Subscribe for More Information
09:20 EDTSMGScotts Miracle-Gro should be bought at current levels, says SunTrust
SunTrust expects Scotts-Miracle to report weaker than expected Q2 results and provide weaker than expected full-year guidance, due to recall and weather issues. However, the firm thinks that investors will quickly shift their focus to fiscal 2016, when it believes the company will benefit from easier comps, favorable commodities, and higher than expected earnings.
July 27, 2015
10:13 EDTTRAKHigh option volume stocks
Subscribe for More Information
10:00 EDTTRAKOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:34 EDTTRAKDealerTrack downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded DealerTrack to Market Perform citing the pending acquisition by Cox Automotive. Wells raised its price target range for shares to $63-$64 from $52-$55.
July 24, 2015
08:04 EDTTRAKCox, Dealertrack receive second DOJ request for additional material
Subscribe for More Information
July 21, 2015
19:00 EDTNUANOn The Fly: After Hours Movers
Subscribe for More Information
16:11 EDTNUANNuance announces resignation of CFO Tom Beaudoin
Nuance announced that it has appointed Daniel Tempesta as its Chief Financial Officer and an Executive Vice President. Tom Beaudoin, who has served as Nuance’s CFO since July 2008, will depart at the end of the month to pursue an opportunity at a smaller, privately held company. Tempesta joined Nuance in March 2008 and most recently has served as the company's Chief Accounting Officer.
16:09 EDTNUANNuance sees Q3 EPS 31c-32c, consensus 28c
Sees Q3 revenue $485M-$489M, consensus $477M. On May 7, 2015, Nuance provided initial guidance for Q3 of $468M-$482M in revenue and 25c-29c in EPS.
July 20, 2015
08:00 EDTCEMPCempra price target raised to $56 from $42 at Roth Capital
Roth Capital analyst Debjit Chattopadhyay raised his price target for Cempra shares to $56 saying the company has "compelling" market opportunity in COPD. The anti-inflammatory property of macrolides make them an ideal add-on therapy in COPD, the analyst tells investors in a research note. His new price target assumes a 65% probability of success in COPD. Chattopadhyay keeps a Buy rating on Cempra.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use